CCNE1 and non-small cell lung carcinoma: Zhang reached a similar conclusion using non-small-cell lung cancer (NSCLC) and found that CDR1as functions as an oncogene that inhibits the anti-tumor effects of miR-7 by upregulation of the proliferation indices Ki-67, EGFR, CCNE1, and PIK3CD [56].